By Dave Andrusko
Assuming someone has not decided to ignore the opening salvos of the Biden-Harris assault on pro-life policies, they know fully well there is every reason in the world for Planned Parenthood President Alexis McGill Johnson to say she is “completely over the moon” over the new pro-abortion administration.
Speaking first of Vice President Kamala Harris, McGill Johnson went on to say in an interview with Business Insider that she was “so excited to support her leadership and support their vision for how we transform health care, as well as sexual reproductive health care.”
Kudos to Mary Margaret Olohan for reminding us of how McGill Johnson bragged of her influence over the new administration and her anticipation of shaping aggressive abortion policies.
For example, Olohan quotes from Business Insider:
“We should be pushing bold agenda items in the name of building back better,” McGill Johnson said, borrowing President Joe Biden’s campaign slogan.
“We are engaging in the policy side, on the education side, on messaging, and personnel—all of the ways that we think can be good policymaking but also support the use of the bully pulpit that the White House carries.”
That interview preceded the flood of executive orders which made Planned Parenthood giddy. That included, of course, terminating the Mexico City, expanded by President Trump into the Protecting Life in Global Health Assistance program, and beginning to open the way for PPFA to again receive hundreds of millions of dollars of Title X family planning monies.
And, rubbing salt into the rawest of wounds, Biden used the 48th anniversary of Roe v. Wade to issue a statement declaring, “The Biden-Harris Administration is committed to codifying Roe v. Wade and appointing judges that respect foundational precedents like Roe.”
McGill Johnson’s wish list didn’t stop there. According to Olohan,she told Business Insider’s Kimberly Leonard
Planned Parenthood is also hoping that the Biden administration will prioritize making medication [chemical] abortion available during the coronavirus pandemic by ending restrictions on abortion pills.
That’s an allusion to the relentless campaign to erase FDA safety precautions when women undergo a two-drug chemical abortion. The FDA requires women to pick up mifepristone, the first of the two drugs, in person, and also that mifepristone be dispensed only by certified health care providers and only in a hospital, clinic, or medical office.
The FDA is supposed to be non-partisan so Biden-Harris have to at least pretend there is a reason to change the policy.
As POLITICO, a reliably pro-abortion publication, wrote:
Though the FDA is a science-focused agency that’s supposed to weigh the drug’s safety and the risk of requiring patients to obtain it in-person during the pandemic, President Joe Biden’s eventual nominee to lead the agency will face pressure from Democratic-aligned groups to lift restrictions on abortion medication.